Rapport Therapeutics (Series B)

Funding Details
Awarder
Inbox
Date Award
August 23, 2023
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$150,000,000

Company Info
Founders
Abraham N. Ceesay
Company Description
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
Market
Neurological diseases
Location
Boston, MA, USA
Coinvestors
ARCH Venture Partners, Cormorant Asset Management, Fidelity Management & Research Company, Goldman Sachs Asset Management, Johnson & Johnson Innovation, Logos Capital, Perceptive Advisors, Sofinnova Ventures, Surveyor Capital, T. Rowe Price Associates, Third Rock Ventures

Links